ClinicalTrials.Veeva
Menu

Find clinical trials for Ovarian Cancer in Atlanta, GA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Endometrial Cancer
Breast Cancer
Ovarian Epithelial Carcinoma
Non-Small-Cell Lung Carcinoma
Cancer
Fallopian Tube Cancer
Colorectal Cancer

Ovarian Cancer trials near Atlanta, GA, USA:

A Phase 1 Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.

The goal of this clinical trial is to learn if OPB-201 is safe in recurrent endometrial and platinum resistant ovarian cancer parti...

Enrolling
Endometrial Cancer
Advanced Endometrial Cancer
Biological: OPB-201

Phase 1

Outpace Bio, Inc.

Atlanta, Georgia, United States and 4 other locations

bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and prima...

Enrolling
Primary Peritoneal Cancer
Platinum-refractory Ovarian Cancer
Drug: Non-platinum chemotherapy: Physician's Choice of gemcitabine, taxane (paclitaxel, docetaxel or nab-paclitaxel) or pegylated liposomal doxorubicin
Drug: Platinum chemotherapy: carboplatin (preferred) or cisplatin

Phase 3

Genelux

Atlanta, Georgia, United States and 32 other locations

positive, recurrent platinum sensitive, high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancer following 1 pri...

Active, not recruiting
Primary Peritoneal Cancer
High Grade Ovarian Cancer
Drug: Mirvetuximab soravtansine
Drug: Carboplatin

Phase 2

AbbVie
AbbVie

Atlanta, Georgia, United States and 70 other locations

Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....

Active, not recruiting
Advanced Ovarian Cancer
FIGO Stage III-IV
Drug: Olaparib 300mg tablets

Phase 3

AstraZeneca
AstraZeneca

Atlanta, Georgia, United States and 176 other locations

Recently updated

study is to compare how well Rina-S works against platinum-resistant ovarian cancer compared to chemotherapy drugs that are already ...

Active, not recruiting
Platinum-resistant Ovarian Cancer
Drug: Topotecan
Drug: Gemcitabine

Phase 3

Genmab
Genmab

Atlanta, Georgia, United States and 176 other locations

letrozole is an effective treatment for people with low-grade serous ovarian cancer (LGSOC). The researchers will also look at the ...

Enrolling
Low-Grade Serous Ovarian Cancer
Drug: Avutometinib
Drug: Letrozole

Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Atlanta, Georgia, United States and 7 other locations

Locations recently updated

This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...

Enrolling
Low Grade Serous Ovarian Cancer
Drug: Defactinib
Drug: Letrozole

Phase 3

Verastem

Atlanta, Georgia, United States and 104 other locations

A Phase 2 study to evaluate the safety and efficacy of TORL-1-23 in patients with advanced ovarian cancer....

Enrolling
Epithelial Ovarian Cancer
Endometrioid Ovarian Cancer
Drug: Pegfilgrastim (drug)
Drug: TORL-1-23

Phase 2

TORL Biotherapeutics

Atlanta, Georgia, United States and 65 other locations

This study will evaluate the safety and efficacy of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer (PROC) With C...

Enrolling
Ovarian Cancer
Drug: INCB123667

Phase 2

Incyte
Incyte

Gainesville, Georgia, United States and 73 other locations

(ZN-c3) in subjects with Platinum-Resistant, High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Part 2 of the...

Enrolling
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Drug: azenosertib

Phase 2

K-Group Beta

Atlanta, Georgia, United States and 88 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems